PE20000465A1 - Preparados efervescentes - Google Patents
Preparados efervescentesInfo
- Publication number
- PE20000465A1 PE20000465A1 PE1999000400A PE00040099A PE20000465A1 PE 20000465 A1 PE20000465 A1 PE 20000465A1 PE 1999000400 A PE1999000400 A PE 1999000400A PE 00040099 A PE00040099 A PE 00040099A PE 20000465 A1 PE20000465 A1 PE 20000465A1
- Authority
- PE
- Peru
- Prior art keywords
- sugar
- components
- alcohol
- procedure
- effervescent
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title abstract 3
- -1 CARBONATES Chemical compound 0.000 abstract 4
- 239000000203 mixture Substances 0.000 abstract 3
- 239000002253 acid Substances 0.000 abstract 2
- 239000003172 expectorant agent Substances 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 150000005846 sugar alcohols Chemical class 0.000 abstract 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 abstract 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 abstract 1
- 229940122957 Histamine H2 receptor antagonist Drugs 0.000 abstract 1
- 239000000150 Sympathomimetic Substances 0.000 abstract 1
- 229940035676 analgesics Drugs 0.000 abstract 1
- 230000000954 anitussive effect Effects 0.000 abstract 1
- 229940069428 antacid Drugs 0.000 abstract 1
- 239000003159 antacid agent Substances 0.000 abstract 1
- 239000000730 antalgic agent Substances 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 230000003266 anti-allergic effect Effects 0.000 abstract 1
- 230000001088 anti-asthma Effects 0.000 abstract 1
- 230000003178 anti-diabetic effect Effects 0.000 abstract 1
- 230000003474 anti-emetic effect Effects 0.000 abstract 1
- 230000002460 anti-migrenic effect Effects 0.000 abstract 1
- 239000000043 antiallergic agent Substances 0.000 abstract 1
- 239000000924 antiasthmatic agent Substances 0.000 abstract 1
- 229940088710 antibiotic agent Drugs 0.000 abstract 1
- 239000002111 antiemetic agent Substances 0.000 abstract 1
- 229940125683 antiemetic agent Drugs 0.000 abstract 1
- 239000000739 antihistaminic agent Substances 0.000 abstract 1
- 229940125715 antihistaminic agent Drugs 0.000 abstract 1
- 239000003434 antitussive agent Substances 0.000 abstract 1
- 229940124584 antitussives Drugs 0.000 abstract 1
- 230000001813 broncholytic effect Effects 0.000 abstract 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 238000001816 cooling Methods 0.000 abstract 1
- 230000003419 expectorant effect Effects 0.000 abstract 1
- 229940066493 expectorants Drugs 0.000 abstract 1
- 230000004927 fusion Effects 0.000 abstract 1
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract 1
- 239000003589 local anesthetic agent Substances 0.000 abstract 1
- 229960005015 local anesthetics Drugs 0.000 abstract 1
- 239000011707 mineral Substances 0.000 abstract 1
- 230000000510 mucolytic effect Effects 0.000 abstract 1
- 229940066491 mucolytics Drugs 0.000 abstract 1
- 229940001470 psychoactive drug Drugs 0.000 abstract 1
- 239000004089 psychotropic agent Substances 0.000 abstract 1
- 230000001975 sympathomimetic effect Effects 0.000 abstract 1
- 239000011782 vitamin Substances 0.000 abstract 1
- 229940088594 vitamin Drugs 0.000 abstract 1
- 229930003231 vitamin Natural products 0.000 abstract 1
- 235000013343 vitamin Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/12—Mucolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Anesthesiology (AREA)
- Emergency Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Nutrition Science (AREA)
- Endocrinology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Immunology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION DE PREPARADOS EFERVESCENTES QUE COMPRENDEN a)UNA COMPOSICION EFERVESCENTE QUE COMPRENDE i)FUENTE DE CO2 TAL COMO CARBONATOS, HIDROGENATOS ALCALINOS, ii)COMPONENTE ACIDO TAL COMO ACIDO ASCORBICO, ACIDOS CARBOXILICOS POLIBASICOS (VITAMINA C); b)PRINCIPIO ACTIVO TAL COMO ANALGESICOS, ANTIACIDOS, ANTIASMATICOS/BRONCOLITICOS, ANTIBIOTICOS, PSICOFARMACOS, ANTIDIABETICOS, ANTIALERGICOS/ANTIHISTAMINICOS, ANTIHIPOTENSORES, ANTITUSIVOS, MUCOLITICOS/EXPECTORANTES, BLOQUEADORES H2, ANESTESICOS LOCALES, ANTIEMETICOS/PROCINETICOS, HIPOLIPEDEMIANTES, AGENTES ANTIMIGRANA, SIMPATICOMIMETICOS, VITAMINAS, MINERALES; c)COADYUVANTE; UNO DE LOS COMPONENTES i), ii) U OTROS COMPONENTES SE DISPERSAN EN EL COADYUVANTE QUE PUEDE SER AZUCAR, AZUCAR-ALCOHOL, AZUCAR FUNDIDOS; EL PROCEDIMIENTO SE CARACTERIZA PORQUE SE TRITURA DURANTE O DESPUES DEL ENFRIAMIENTO UNA MASA DE FUSION DE i), ii) Y EL AZUCAR, AZUCAR-ALCOHOL QUE ALCANZA UNA TEMPERATURA DE 20°C A 200°C; LUEGO SE MEZCLA CON EL PRINCIPIO ACTIVO CON LOS COMPONENTES i), ii) QUE TODAVIA FALTAN DE LA COMPOSICION EFERVESCENTE A; LUEGO LA MEZCLA SE PREPARA EN COMPRIMIDOS
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19822036A DE19822036A1 (de) | 1998-05-15 | 1998-05-15 | Brausezubereitungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20000465A1 true PE20000465A1 (es) | 2000-07-07 |
Family
ID=7868010
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1999000400A PE20000465A1 (es) | 1998-05-15 | 1999-05-13 | Preparados efervescentes |
Country Status (30)
| Country | Link |
|---|---|
| EP (1) | EP1077684B1 (es) |
| JP (1) | JP4452403B2 (es) |
| KR (1) | KR100629817B1 (es) |
| AR (1) | AR016473A1 (es) |
| AT (1) | ATE246494T1 (es) |
| AU (1) | AU3929799A (es) |
| BR (1) | BR9910454A (es) |
| CA (1) | CA2331671C (es) |
| CO (1) | CO4830457A1 (es) |
| CZ (1) | CZ300778B6 (es) |
| DE (2) | DE19822036A1 (es) |
| DK (1) | DK1077684T3 (es) |
| EE (1) | EE04701B1 (es) |
| ES (1) | ES2203134T3 (es) |
| GT (1) | GT199900062A (es) |
| HN (1) | HN1999000067A (es) |
| HR (1) | HRP20000781B1 (es) |
| HU (1) | HU224034B1 (es) |
| ID (1) | ID27441A (es) |
| IL (1) | IL139240A (es) |
| NO (1) | NO20005722L (es) |
| PA (1) | PA8472001A1 (es) |
| PE (1) | PE20000465A1 (es) |
| PL (1) | PL194347B1 (es) |
| PT (1) | PT1077684E (es) |
| SI (1) | SI1077684T1 (es) |
| SK (1) | SK284621B6 (es) |
| TR (1) | TR200003357T2 (es) |
| UY (1) | UY25510A1 (es) |
| WO (1) | WO1999059553A1 (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6649186B1 (en) * | 1996-09-20 | 2003-11-18 | Ethypharm | Effervescent granules and methods for their preparation |
| AU777234B2 (en) * | 1999-02-11 | 2004-10-07 | Hexal Ag | Pharmaceutical effervescent formulation containing metamizol |
| FR2823668B1 (fr) * | 2001-04-20 | 2004-02-27 | Ethypharm Lab Prod Ethiques | Comprimes effervescents orodispersibles |
| DE602006001295D1 (de) * | 2005-02-03 | 2008-07-03 | Nycomed Pharma As | Schmelzgranulation einer zusammensetzung mit einer calziumhaltigen verbindung |
| GR1007299B (el) * | 2010-03-24 | 2011-06-06 | Uni - Pharma Κλεων Τσετης Φαρμακευτικα Εργαστηρια Αβεε Με Δ.Τ. Uni-Pharma Αβεε, | Πρωτοτυπη αναβραζουσα φαρμακευτικη συνθεση υδροχλωρικης μετφορμινης με τη μορφη δισκιου |
| WO2013022410A2 (en) | 2011-08-08 | 2013-02-14 | Mahmut Bilgic | Production method for effervescent formulations comprising dexketoprofen |
| BR112017005362A2 (pt) | 2014-09-17 | 2018-01-23 | Steerlife India Private Ltd | composição, forma de dosagem sólida oral, processo para preparação de grânulos efervescentes porosos, processador de parafuso duplo, e, grânulos efervescentes porosos. |
| US11559483B2 (en) * | 2015-07-10 | 2023-01-24 | Sanjay Gupta | Nasal foam via cribriform plate for medication delivery to the brain and/or body and for nasal moisturization and hygiene |
| WO2017098481A1 (en) | 2015-12-12 | 2017-06-15 | Steerlife India Private Limited | Effervescent compositions of metformin and processes for preparation thereof |
| JP2018183067A (ja) * | 2017-04-24 | 2018-11-22 | 株式会社松原製餡所 | 発泡性添加物、及び、餡食品 |
| WO2021076506A1 (en) * | 2019-10-17 | 2021-04-22 | Isp Investments Llc | A stable effervescent co-processed excipient composition and a process for preparing the same |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4004036A (en) * | 1966-05-31 | 1977-01-18 | Alberto Culver Company | Effervescent molded triturate tablets |
| US3653914A (en) * | 1970-03-20 | 1972-04-04 | Alberto Culver Co | Production of tablets |
| DE69102900T3 (de) * | 1990-02-14 | 1998-04-09 | Otsuka Pharma Co Ltd | Brausemischung, deren Herstellung sowie Verwendung. |
| RU2096955C1 (ru) * | 1991-03-01 | 1997-11-27 | Е.И.Дюпон Де Немур Энд Компани | Вододиспергируемая гранулированная пестицидная композиция, получаемая методом экструзии, и способ ее получения |
| MX9300110A (es) * | 1992-01-13 | 1994-07-29 | Gerhard Gergely | Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion. |
| HU217125B (hu) * | 1993-03-10 | 1999-11-29 | Béres Rt. | Cukor- és nátriummentes pezsgőtabletta és -granulátum és eljárás azok előállítására |
| CN1060037C (zh) * | 1993-09-09 | 2001-01-03 | 杰哈德·盖尔盖伊 | 泡腾颗粒料及其制造方法 |
| GB2307857B (en) * | 1995-12-04 | 1999-01-27 | Euro Celtique Sa | An effervescent formulation |
-
1998
- 1998-05-15 DE DE19822036A patent/DE19822036A1/de not_active Withdrawn
-
1999
- 1999-04-29 GT GT199900062A patent/GT199900062A/es unknown
- 1999-05-03 IL IL13924099A patent/IL139240A/xx not_active IP Right Cessation
- 1999-05-03 DK DK99922151T patent/DK1077684T3/da active
- 1999-05-03 ES ES99922151T patent/ES2203134T3/es not_active Expired - Lifetime
- 1999-05-03 WO PCT/EP1999/002969 patent/WO1999059553A1/de not_active Ceased
- 1999-05-03 HU HU0101822A patent/HU224034B1/hu active IP Right Grant
- 1999-05-03 CZ CZ20004171A patent/CZ300778B6/cs not_active IP Right Cessation
- 1999-05-03 JP JP2000549218A patent/JP4452403B2/ja not_active Expired - Lifetime
- 1999-05-03 EP EP99922151A patent/EP1077684B1/de not_active Expired - Lifetime
- 1999-05-03 HR HR20000781A patent/HRP20000781B1/xx not_active IP Right Cessation
- 1999-05-03 PT PT99922151T patent/PT1077684E/pt unknown
- 1999-05-03 ID IDW20002354A patent/ID27441A/id unknown
- 1999-05-03 SK SK1706-2000A patent/SK284621B6/sk not_active IP Right Cessation
- 1999-05-03 AT AT99922151T patent/ATE246494T1/de active
- 1999-05-03 BR BR9910454-7A patent/BR9910454A/pt not_active IP Right Cessation
- 1999-05-03 DE DE59906519T patent/DE59906519D1/de not_active Expired - Lifetime
- 1999-05-03 PL PL99344140A patent/PL194347B1/pl unknown
- 1999-05-03 CA CA002331671A patent/CA2331671C/en not_active Expired - Lifetime
- 1999-05-03 KR KR1020007012745A patent/KR100629817B1/ko not_active Expired - Fee Related
- 1999-05-03 EE EEP200000650A patent/EE04701B1/xx not_active IP Right Cessation
- 1999-05-03 TR TR2000/03357T patent/TR200003357T2/xx unknown
- 1999-05-03 AU AU39297/99A patent/AU3929799A/en not_active Abandoned
- 1999-05-03 SI SI9930356T patent/SI1077684T1/xx unknown
- 1999-05-06 PA PA19998472001A patent/PA8472001A1/es unknown
- 1999-05-10 HN HN1999000067A patent/HN1999000067A/es unknown
- 1999-05-10 AR ARP990102193A patent/AR016473A1/es not_active Application Discontinuation
- 1999-05-13 CO CO99029806A patent/CO4830457A1/es unknown
- 1999-05-13 PE PE1999000400A patent/PE20000465A1/es not_active Application Discontinuation
- 1999-05-14 UY UY25510A patent/UY25510A1/es not_active IP Right Cessation
-
2000
- 2000-11-13 NO NO20005722A patent/NO20005722L/no not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20000465A1 (es) | Preparados efervescentes | |
| Pendergrast et al. | Thyroid cancer and thyrotoxicosis in the United States: their relation to endemic goiter | |
| AU653026B2 (en) | Physiologically active polypeptide-containing pharmaceutical composition | |
| BG103253A (en) | Pharmaceutical compositions containing effervescent acid base pair | |
| EP0662840A1 (en) | Pharmaceutical compositions and methods for treating cold symptoms | |
| ES2072447T3 (es) | Locion analgesica externa y procedimiento de preparacion. | |
| JPS60222427A (ja) | 発泡性無水組成物 | |
| EP0200490A3 (en) | Compositions for noninvasive administration of sedatives, analgesics, and anesthetics | |
| ES8600733A1 (es) | Un metodo para preparar una mezcla liofilizada de polvo absorbible y acido aminocaproico | |
| AR021922A1 (es) | Formulaciones farmaceuticas en aerosol que contienen fluoroalcanos, budesonido y formoterol. | |
| ATE151982T1 (de) | Verschäumbares mittel zur pharmazeutischen verwendung, dessen verwendung sowie behandlungsverfahren | |
| CO5160272A1 (es) | Combinacion de cerivastatina y fibratos | |
| NO830491L (no) | Oralt anti-diabetisk preparat. | |
| CO5540295A2 (es) | Comprimido para tragar que comprende paracetamol | |
| DK0693926T3 (da) | Ny farmaceutisk sammensætning til fremstilling af et stabilt pulver indeholdende en kombination af acetylsalicylsyre og metoclopramid som aktiv bestanddel. | |
| DK0472588T3 (da) | Præparat og fremgangsmåde til nedsættelse af mave-tarmlidelse som følge af alfa-D-galactosidbundne sukkere | |
| SE8204288L (sv) | Analgetisk komposition innehallande n-acetyl-p-aminofenol i kombination med ett antacidum | |
| UA37206C2 (uk) | Фармацевтична композиція, яка містить алкілсульфонамід-агоніст 5нті- подібного рецептора для ректального введення | |
| Pena | Etodolac: analgesic effects in musculoskeletal and postoperative pain | |
| GR3034549T3 (en) | Anhydrous composition comprising lactulose | |
| JPS6434915A (en) | Drug preparation for skin | |
| ES2064104T3 (es) | Procedimiento de preparacion de composiciones farmaceuticas del tipo de liberacion prolongada destinadas a la administracion por via oral. | |
| ATE86965T1 (de) | Pharmazeutische kompositionen zum behandeln von adrenoleukodystrophie. | |
| ES8802560A1 (es) | Un metodo para la preparacion de derivados estables efervescentes de acido acetilsalicilico con propiedades antihistaminicas. | |
| AR030087A1 (es) | Una composicion oral |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |